Co-Diagnostics advances Ebola PCR test development with CoSara venture Jun 2, 2026 09:01AM
Co-Diagnostics (CODX) Misses Q1 EPS by 406c May 14, 2026 04:42PM
Co-Diagnostics (CODX) files $150M mixed shelf May 12, 2026 04:34PM
Co-Diagnostics ships TB testing materials to India for clinical studies Mar 25, 2026 08:02AM
Co-Diagnostics receives Japanese patent for PCR platform technology Mar 12, 2026 09:02AM


Jan 23, 2026 07:53AM Maxim Group Downgrades Co-Diagnostics (CODX) to Hold
Dec 29, 2025 09:00AM Co-Diagnostics receives Australian patent for PCR platform technology
Nov 26, 2025 08:59AM Maxim Group Starts Co-Diagnostics (CODX) at Buy
Nov 13, 2025 04:03PM Co-Diagnostics (CODX) Reports In-Line Q3 EPS
Oct 27, 2025 08:45AM Co-Diagnostics forms joint venture in Saudi Arabia for PCR platform
Oct 16, 2025 09:30AM Co-Diagnostics develops sample prep instrument for tuberculosis testing
Sep 16, 2025 09:30AM Co-Diagnostics signs MOU for Saudi Arabia joint venture
Aug 19, 2025 06:43AM H.C. Wainwright Reiterates Neutral Rating on Co-Diagnostics (CODX)
Aug 14, 2025 04:02PM Co-Diagnostics (CODX) Tops Q2 EPS by 43c
May 8, 2025 06:37PM Co-Diagnostics (CODX) Tops Q1 EPS by 10c
Mar 31, 2025 06:41AM Co-Diagnostics (CODX) PT Lowered to $1 at H.C. Wainwright
Mar 6, 2025 03:31PM Co-Diagnostics (CODX) Wins Dismissal of Class Action Lawsuit
Feb 21, 2025 04:01PM Co-Diagnostics (CODX) to Submit Enhanced Version of COVID-19 Test to FDA for 510(k) Clearance
Nov 7, 2024 04:37PM Co-Diagnostics (CODX) Tops Q3 EPS by 1c
Sep 5, 2024 09:30AM Co-Diagnostics (CODX) Completes Updated Clade Ib Analysis of 2-Gene Mpox RUO Test
Aug 13, 2024 06:41AM Co-Diagnostics (CODX) PT Lowered to $1.50 at H.C. Wainwright
Aug 8, 2024 04:16PM Co-Diagnostics (CODX) Tops Q2 EPS by 9c
Jun 14, 2024 09:30AM Co-Diagnostics (CODX) Submits First FDA 510(k) Application for Co-Dx PCR Pro Platform